What can the lived experience of participating in risky HIV cure-related studies establish?

Journal of Medical Ethics:medethics-2017-104593 (2018)
  Copy   BIBTEX

Abstract

This response to Gail Henderson et al argues that they were right that interviewees’ appraisals of cure study participation should inform protocol review decisions, but wrong to take these appraisals at face value.

Categories

Keywords

Reprint years

DOI

10.1136/medethics-2017-104593

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,676

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Reconceptualising risk–benefit analyses: the case of HIV cure research.Robert Steel - 2020 - Journal of Medical Ethics 46 (3):212-219.
Ethics of HIV cure research: an unfinished agenda. [REVIEW]Jeremy Sugarman, John A. Sauceda, Brandon Brown, Parya Saberi, Mallory O. Johnson, Laney Henley, Samuel Ndukwe, Hursch Patel, Morénike Giwa Onaiwu, Danielle M. Campbell, David Palm, Orbit Clanton, David Kelly, Jan Kosmyna, Michael Louella, Laurie Sylla, Christopher Roebuck, Nora Jones, Lynda Dee, Jeff Taylor, John Kanazawa & Karine Dubé - 2021 - BMC Medical Ethics 22 (1):1-14.
Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.Jane Simoni, Steven G. Deeks, Michael J. Peluso, John A. Sauceda, Boro Dropulić, Kim Anthony-Gonda, Jen Adair, Jeff Taylor, Lynda Dee, Jeff Sheehy, Laurie Sylla, Michael Louella, Hursch Patel, John Kanazawa & Karine Dubé - 2022 - BMC Medical Ethics 23 (1):1-17.
Ethical considerations for HIV cure-related research at the end of life.Karine Dubé, Sara Gianella, Susan Concha-Garcia, Susan J. Little, Andy Kaytes, Jeff Taylor, Kushagra Mathur, Sogol Javadi, Anshula Nathan, Hursch Patel, Stuart Luter, Sean Philpott-Jones, Brandon Brown & Davey Smith - 2018 - BMC Medical Ethics 19 (1):83.
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.Gail E. Henderson, Holly L. Peay, Eugene Kroon, Rosemary Jean Cadigan, Karen Meagher, Thidarat Jupimai, Adam Gilbertson, Jill Fisher, Nuchanart Q. Ormsby, Nitiya Chomchey, Nittaya Phanuphak, Jintanat Ananworanich & Stuart Rennie - 2017 - Journal of Medical Ethics:medethics-2017-104433.
The psychology of “cure” - unique challenges to consent processes in HIV cure research in South Africa.Keymanthri Moodley, Ciara Staunton, Theresa Rossouw, Malcolm de Roubaix, Zoe Duby & Donald Skinner - 2019 - BMC Medical Ethics 20 (1):9.
Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States.Karine Dubé, Davey Smith, Brandon Brown, Susan Little, Steven Hendrickx, Stephen A. Rawlings, Samuel Ndukwe, Hursch Patel, Christopher Christensen, Andy Kaytes, Jeff Taylor, Susanna Concha-Garcia, Sara Gianella & John Kanazawa - 2022 - BMC Medical Ethics 23 (1):1-17.
Comment: Well-Being Can Improve Health by Shaping Stress Appraisals.Elliott Kruse & Kate Sweeny - 2018 - Emotion Review 10 (1):63-65.
Synergies, tensions and challenges in HIV prevention, treatment and cure research: exploratory conversations with HIV experts in South Africa.Keymanthri Moodley, Theresa Rossouw, Ciara Staunton & Christopher J. Colvin - 2016 - BMC Medical Ethics 17 (1):26.
For love and money: the need to rethink benefits in HIV cure studies.Emily Largent - 2017 - Journal of Medical Ethics 43 (2):96-99.

Analytics

Added to PP
2018-01-12

Downloads
43 (#515,708)

6 months
13 (#250,881)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Nir Eyal
Harvard University

Citations of this work

Add more citations

References found in this work

Add more references